Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
1579
-
Total 13F shares, excl. options
-
1.25B
-
Shares change
-
+235M
-
Total reported value, excl. options
-
$55.5B
-
Value change
-
+$10.5B
-
Put/Call ratio
-
0.89
-
Number of buys
-
866
-
Number of sells
-
-582
-
Price
-
$44.41
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q1 2017
1,717 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q1 2017.
ABBOTT LABORATORIES - COM (ABT) has 1,579 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.25B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (127M shares), BlackRock Inc. (106M shares), STATE STREET CORP (80.5M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (51.9M shares), WELLINGTON MANAGEMENT GROUP LLP (36.4M shares), Bank of New York Mellon Corp (33.8M shares), Capital Research Global Investors (32.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (27.6M shares), NORTHERN TRUST CORP (26.1M shares), and GOLDMAN SACHS GROUP INC (23.8M shares).
This table shows the top 1579 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.